223 (Lithium carbonate extended release 300 mg)
Pill imprint 223 has been identified as Lithium carbonate extended release 300 mg.
Lithium is used in the treatment of bipolar disorder; borderline personality disorder; depression; schizoaffective disorder; mania (and more), and belongs to the drug class miscellaneous antipsychotic agents. There is positive evidence of human fetal risk during pregnancy. Lithium 300 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for 223
- 300 mg
- Prescription only
- Drug Class:
- Miscellaneous antipsychotic agents
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Glenmark Generics Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- sodium chloride
sodium starch glycolate type A potato
sodium lauryl sulfate
hypromellose 2910 (15000 mPa.s)
polyethylene glycol 400
ferric oxide red
More about lithium
- Lithium controlled-release and extended-release tablets
- Lithium syrup
- Lithium (Advanced Reading)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.